WPC
TLSI icon

White Pine Capital’s TriSalus Life Sciences TLSI Stock Holding History

White Pine Capital’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$655K Buy
163,810
+105,259
+180% +$515K 0.18% 135
2025
Q4 		$409K Sell
58,551
-1,182
-2% -$6.62K 0.11% 172
2025
Q3 		$278K Buy
+59,733
New +$280K 0.08% 206

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

White Pine Capital's TLSI Position: Q1 2026 in Review

White Pine Capital increased its TriSalus Life Sciences (TLSI) stake by 180% in Q1 2026, buying an estimated $515K and bringing the position to 163,810 shares worth $655K. The position accounts for 0.18% of the portfolio, ranked #135.

White Pine Capital first reported a position in TLSI in Q3 2025 and has held it in 3 quarters since. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • White Pine Capital held 163,810 shares of TriSalus Life Sciences worth $655K as of Q1 2026.
  • White Pine Capital bought 105,259 TriSalus Life Sciences shares in Q1 2026, an estimated $515K.
  • TriSalus Life Sciences made up 0.18% of White Pine Capital's portfolio in Q1 2026, its #135 holding.
  • White Pine Capital first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on White Pine Capital's 13F filing for Q1 2026, filed 11 May 2026.